✦ LIBER ✦

PCN43 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN ITALY

✍ Scribed by S Ravera; S Walzer; J Ray

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN44 COST COMPARISON OF ERLOTINIB VERSU

✍ J Castro de Carpeño; AJ Castro-Gómez; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

A cross-market cost comparison of erloti

✍ Nuijten, Mark J.C.; de Castro Carpeño, Javier; Chouaid, Christos; Vergnenègre, A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 375 KB

A randomised phase II study of pemetrexe

✍ Dittrich, Christian; Papai-Szekely, Zsolt; Vinolas, Nuria; Sederholm, Christer; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 517 KB

PCN90 Cost-Effectiveness Analysis of Erl

✍ Nguyen, T.T.T.; Yagudina, R.; Kulikov, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCN20 MAINTENANCE ERLOTINIB VERSUS PEMET

✍ R Casciano; H Bischoff; M Nuijten; E Malangone; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PCN17 Indirect Comparison of the Efficac

✍ C. Pereira; M. Sanches; J.F. Loff 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB